- Home
- KLIC vs SPRY Comparison
KLIC vs SPRY Comparison
Compare KLIC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLIC
- SPRY
- Stock Information
- Founded
- KLIC 1951
- SPRY 2015
- Country
- KLIC United States
- SPRY United States
- Employees
- KLIC N/A
- SPRY N/A
- Industry
- KLIC Semiconductors
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- KLIC Technology
- SPRY Health Care
- Exchange
- KLIC Nasdaq
- SPRY Nasdaq
- Market Cap
- KLIC 1.7B
- SPRY 1.8B
- IPO Year
- KLIC N/A
- SPRY N/A
- Fundamental
- Price
- KLIC $40.34
- SPRY $10.31
- Analyst Decision
- KLIC Strong Buy
- SPRY Strong Buy
- Analyst Count
- KLIC 3
- SPRY 5
- Target Price
- KLIC $48.33
- SPRY $31.00
- AVG Volume (30 Days)
- KLIC 517.6K
- SPRY 3.0M
- Earning Date
- KLIC 11-12-2025
- SPRY 11-12-2025
- Dividend Yield
- KLIC 2.03%
- SPRY N/A
- EPS Growth
- KLIC N/A
- SPRY N/A
- EPS
- KLIC 0.11
- SPRY N/A
- Revenue
- KLIC $657,842,000.00
- SPRY $112,339,000.00
- Revenue This Year
- KLIC N/A
- SPRY N/A
- Revenue Next Year
- KLIC $12.94
- SPRY $188.92
- P/E Ratio
- KLIC $353.48
- SPRY N/A
- Revenue Growth
- KLIC N/A
- SPRY 22367.80
- 52 Week Low
- KLIC $26.63
- SPRY $9.34
- 52 Week High
- KLIC $52.08
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- KLIC 53.21
- SPRY 41.76
- Support Level
- KLIC $40.05
- SPRY $9.72
- Resistance Level
- KLIC $42.23
- SPRY $10.99
- Average True Range (ATR)
- KLIC 1.21
- SPRY 0.59
- MACD
- KLIC -0.25
- SPRY 0.28
- Stochastic Oscillator
- KLIC 7.69
- SPRY 57.52
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.